Tag: Farma
Aelis Farma strengthens its management with the appointment of Arsène Guekam as Chief Corporate Development Officer – 01/17/2024 at 6:00 p.m.
Bordeaux, January 17, 2024 – 6:00 p.m. CET – Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS, PEA-PME eligible), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain…
Aelis Farma announces the finalization of patient recruitment for the phase 2b study with AEF0117 in the treatment of cannabis addiction – 01/09/2024 at 6:00 p.m.
• As planned, 333 patients were randomized by the end of December 2023 across 11 clinical centers in the United States • This important milestone should make it possible to…
Aelis Farma: positive results from non-clinical regulatory studies for the entry of AEF0117 into a phase 3 clinical study – 07/11/2023 at 6:35 p.m.
Positive results from in vivo toxicological studies in which AEF0117 demonstrates a very favorable therapeutic index, more than 13,000 times higher than the active dose Finalization of the development of…
Aelis Farma: contribution of €100k to the liquidity contract
A.S. Published on 02/10/2023 at 9:05 p.m. Photo credit © Mathieu Stern / Unsplash (Boursier.com) —…
Aelis Farma publishes its 2023 half-year financial results and confirms its development prospects – 09/25/2023 at 6:00 p.m.
Bordeaux, September 25, 2023 – 6:00 p.m. CEST – Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS, PEA-PME eligible), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain…
Aelis Farma: CEO and co-founder rewarded by his peers – 08/29/2023 at 10:21
(CercleFinance.com) – Dr. Pier Vincenzo Piazza, co-founder and CEO of Aelis Farma, has received an Excellence Award from the European Society for Behavioral Pharmacology (EBPS), the Institute announced on Tuesday.…
Aelis Farma: EBPS Excellence Prize awarded to Pier Vincenzo Piazza – 2023-08-28 at 17:45
Pier Vincenzo Piazza, CEO of Aelis Farma, receives the Excellence Award from the European Society for Behavioral Pharmacology (EBPS) The prize recognizes Pier Vincenzo Piazza’s contribution to the advancement of…
Aelis Farma: positive opinion from the DSMB for the continuation of the phase 2b clinical study with AEF0117 in cannabis addiction – 07/05/2023 at 07:00
Aelis Farma receives the positive opinion of the DSMB for the continuation without change to the protocol of its phase 2b clinical study with AEF0117 in cannabis addiction The excellent…
Aelis Farma: received a positive opinion from the DSMB – 07/05/2023 at 07:41
(CercleFinance.com) – Aelis Farma has received the positive opinion of the Data Safety Monitoring Board (DSMB) for the continuation without change to the protocol of its phase 2b clinical study…
Aelis Farma: efficacy of AEF0217 in a mouse genetic model of autism spectrum disorder – 06/12/2023 at 07:05
Preclinical data showing efficacy of AEF0217 in a mouse genetic model of autism spectrum disorder presented at the 2nd European Conference on Phelan-McDermid Syndrome The 2nd European Conference on Phelan-McDermid…
Aelis Farma: promising results for AEF0117
(CercleFinance.com) – Aelis Farma announces today the publication of a series of studies around AEF0117, its first drug candidate dedicated to the treatment of disorders related to excessive cannabis consumption…
Aelis Farma: participates in World Down Syndrome Day
By Alexandra Saintpierre Published on 03/21/2023 at 6:11 p.m. Photo credit © Boursier.com / Kronos Agenda (Boursier.com)…